Comparison of gait in progressive supranuclear palsy, Parkinson’s disease and healthy older adults

BMC Neurology

Table 2 Summary gait data

	SLCrel slope	SLCrel intercept	SLCrelR ²	Min nSL	Max nSL	Range nSL	Min cad	Max cad	Range cad
PSP	0.011 (0.004)	1.14 (0.20)	0.92 (0.08)	0.9 (0.3)	1.4 (0.3)	0.57 (0.21)	74.9 (9.7)	128.9 (13.5)	54.1 (18.2)
PD (n=18)	0.011 (0.004)	1.35 (0.22)	0.94 (0.06)	1.1 (0.2)	1.7 (0.2)	0.55 (0.22)	82.7 (11.6)	137.8 (12.3)	55.1 (15.1)
HOA	0.011 (0.005)	1.48 (0.07)	0.95 (0.04)	1.3 (0.1)	1.9 (0.2)	0.68 (0.17)	78.1 (14.0)	147.8 (12.7)	69.6 (22.1)
	P = 0.75	F _2,56 = 17.7, P < 0.001	P = 0.15	F _2,56 = 15.1, P < 0.001	F _2,56 = 23.4, P < 0.001	P = 0.23	P = 0.13	F _2,56 = 10.5, P < 0.001	F _2,56 = 4.3, P = 0.02

Mean (SD) for each group for the measures taken from ten walks (two each at self-selected very slow, slow, preferred, fast and very fast speeds). Note the stride length – cadence relationship (SLCrel) measures excluded walks with cadence >150steps/min and two outlying PD participants’ data was excluded
SLCrel stride length versus cadence relationship, nSL normalized stride length, cad=cadence, PSP progressive supranuclear palsy, PD Parkinson’s disease, HOA healthy older adult.

ISSN: 1471-2377